Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Operating Expenses: 2009-2024

Historic Operating Expenses for Assembly Biosciences (ASMB) over the last 14 years, with Dec 2024 value amounting to $73.9 million.

  • Assembly Biosciences' Operating Expenses rose 21.75% to $21.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.6 million, marking a year-over-year increase of 7.86%. This contributed to the annual value of $73.9 million for FY2024, which is 2.97% up from last year.
  • Latest data reveals that Assembly Biosciences reported Operating Expenses of $73.9 million as of FY2024, which was up 2.97% from $71.8 million recorded in FY2023.
  • In the past 5 years, Assembly Biosciences' Operating Expenses ranged from a high of $143.9 million in FY2020 and a low of $71.8 million during FY2023.
  • For the 3-year period, Assembly Biosciences' Operating Expenses averaged around $80.0 million, with its median value being $73.9 million (2024).
  • As far as peak fluctuations go, Assembly Biosciences' Operating Expenses increased by 21.24% in 2020, and later slumped by 32.26% in 2022.
  • Yearly analysis of 5 years shows Assembly Biosciences' Operating Expenses stood at $143.9 million in 2020, then decreased by 3.43% to $138.9 million in 2021, then slumped by 32.26% to $94.1 million in 2022, then dropped by 23.70% to $71.8 million in 2023, then climbed by 2.97% to $73.9 million in 2024.